Chong Kun Dang Enters the Hypertension Treatment Market: Should Investors Pay Attention to Telminuvo’s Approval? Chong Kun Dang’s newly developed hypertension treatment, Telminuvo, has received approval from the Ministry of Food and Drug Safety (MFDS). How will this news impact Chong Kun Dang Holdings’ stock price? This article delves into the significance of Telminuvo’s approval, … Read more
Chong Kun Dang’s New Hypertension Drug Telminuvo Approved: Is it an Investment Opportunity? Chong Kun Dang has secured a new growth engine with the domestic approval of Telminuvo (CKD-828). However, potential risks exist, including recent sluggish performance and intensified market competition. This article analyzes the implications of Telminuvo’s approval and key factors investors should consider, … Read more
A New Game Changer in the Hypertension Treatment Market? News of Chong Kun Dang’s application for approval of its new hypertension drug ‘Telminuvo’ has caught the attention of investors. Expected to launch in the second half of 2025, what impact will this new drug have on the growth of Chong Kun Dang Holdings? This article … Read more
A Game Changer in Hypertension Treatment? Analyzing Chong Kun Dang’s ‘Telminuvo Tab.’ Chong Kun Dang has sent ripples through the pharmaceutical market with its application for domestic approval of its new hypertension drug, Telminuvo Tab. Having shown positive results in Phase 3 clinical trials, could Telminuvo be the new growth engine for Chong Kun Dang? … Read more